Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study-Reference-Cited by-同舟云学术

Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study

Published:2019-05-08 Issue:5 Volume:14 Page:e0216750
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Song Tae-Jin,Kim Jinkwon^ORCID

Funder

National Research Foundation of Korea (NRF) funded by the Ministry of Education

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference47 articles.

1. Executive Summary of Stroke Statistics in Korea 2018: A Report from the Epidemiology Research Council of the Korean Stroke Society;JY Kim;J Stroke,2018

2. Aspiration pneumonia after stroke: intervention and prevention;JR Armstrong;The Neurohospitalist,2011

3. Effectiveness and Safety of Antibiotics for Preventing Pneumonia and Improving Outcome after Acute Stroke: Systematic Review and Meta-analysis;MS Badve;J Stroke Cerebrovasc Dis,2018

4. Comparison of Characteristics of Stroke-Associated Pneumonia in Stroke Care Units in Indonesia and Japan;IM Sari;J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc,2017

5. Proton-pump inhibitor use and the risk for community-acquired pneumonia;M Sarkar;Ann Intern Med,2008

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning-based survival analysis approaches for predicting the risk of pneumonia post-stroke discharge;International Journal of Medical Informatics;2024-06

2. Investigating the link between antipsychotic use and post-stroke infections in older people: multi-centre propensity score analysis;Age and Ageing;2024-06-01

3. Electroacupuncture ameliorates gastrointestinal dysfunction by modulating DMV cholinergic efferent signals to drive the vagus nerve in p-MCAO rats;Heliyon;2024-04

4. The Research Progress on Post-Stroke Pneumonia;Advances in Clinical Medicine;2024

5. Commonly prescribed medications and risk of pneumonia and all-cause mortality in people with idiopathic pulmonary fibrosis: a UK population-based cohort study;2023-11-08